S&P 500 Futures
(0.15%) 5 162.25 points
Dow Jones Futures
(0.14%) 38 886 points
Nasdaq Futures
(0.07%) 18 013 points
Oil
(0.78%) $78.72
Gas
(0.47%) $2.15
Gold
(0.62%) $2 323.00
Silver
(2.03%) $27.23
Platinum
(0.12%) $966.45
USD/EUR
(0.02%) $0.929
USD/NOK
(-0.16%) $10.86
USD/GBP
(-0.10%) $0.796
USD/RUB
(0.36%) $91.78

Actualizaciones en tiempo real para Dimerix Ltd [DXB.AX]

Bolsa: ASX Industria: Pharmaceuticals, Biotechnology & Life Sciences
Última actualización6 may 2024 @ 02:10

-2.78% $ 0.350

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 02:10):
Profile picture for Dimerix Ltd

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease...

Stats
Volumen de hoy 5.66M
Volumen promedio 4.57M
Capitalización de mercado 192.39M
EPS $0 ( 2024-02-25 )
Próxima fecha de ganancias ( $0 ) 2024-07-25
Last Dividend $1.237 ( 1999-09-24 )
Next Dividend $0 ( N/A )
P/E -11.67
ATR14 $0.00100 (0.29%)

Volumen Correlación

Largo: 0.08 (neutral)
Corto: 0.00 (neutral)
Signal:(45.72) Neutral

Dimerix Ltd Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dimerix Ltd Correlación - Moneda/Commodity

The country flag -0.20
( neutral )
The country flag 0.39
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.75
( moderate )

Dimerix Ltd Finanzas

Annual 2023
Ingresos: $8.98M
Beneficio Bruto: $8.93M (99.38 %)
EPS: $-0.0424
FY 2023
Ingresos: $8.98M
Beneficio Bruto: $8.93M (99.38 %)
EPS: $-0.0424
FY 2023
Ingresos: $0
Beneficio Bruto: $0 (0.00 %)
EPS: $0
FY 2022
Ingresos: $6.46M
Beneficio Bruto: $6.41M (99.22 %)
EPS: $-0.0350

Financial Reports:

No articles found.

Dimerix Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Dimerix Ltd Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.82 - low (60.09%) | Divividend Growth Potential Score: 0.313 - No dividend growth expected in the near future
Information
First Dividend $6.93 1998-09-18
Last Dividend $1.237 1999-09-24
Next Dividend $0 N/A
Payout Date 1999-05-21
Next Payout Date N/A
# dividends 2 --
Total Paid Out $8.16 --
Avg. Dividend % Per Year 0.00% --
Score 1.29 --
Div. Sustainability Score 4.82
Div.Growth Potential Score 0.313
Div. Directional Score 2.57 --
Next Divdend (Est)
(2024-06-24)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
1.29
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PMV.AX Ex Dividend Knight 2023-06-20 Semi-Annually 0 0.00%
ARB.AX Ex Dividend Knight 2023-10-05 Semi-Annually 0 0.00%
IDX.AX Ex Dividend Junior 2023-08-31 Semi-Annually 0 0.00%
SDG.AX Ex Dividend Knight 2023-10-24 Quarterly 0 0.00%
CAR.AX Ex Dividend Knight 2023-09-15 Semi-Annually 0 0.00%
MAH.AX Ex Dividend Knight 2023-09-19 Sporadic 0 0.00%
TGF.AX Ex Dividend Junior 2023-09-07 Semi-Annually 0 0.00%
CTE.AX Ex Dividend Knight 2023-09-07 Annually 0 0.00%
NHC.AX Ex Dividend Knight 2023-10-23 Annually 0 0.00%
YAL.AX Ex Dividend Knight 2023-09-05 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1.1921.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.7201.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-2.831.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM4.840.80010.008.00[1 - 3]
quickRatioTTM4.840.80010.008.00[0.8 - 2.5]
cashRatioTTM4.761.50010.0010.00[0.2 - 2]
debtRatioTTM0.0947-1.5008.42-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.001742.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM0.001722.0010.0010.00[0 - 20]
debtEquityRatioTTM0.832-1.5006.67-10.00[0 - 2.5]
grossProfitMarginTTM1.0001.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM-2.181.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4941.0008.378.37[0.2 - 2]
assetTurnoverTTM0.6040.8009.317.44[0.5 - 2]
Total Score4.82

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-13.441.000-1.4590[1 - 100]
returnOnEquityTTM-2.832.50-10.00-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.001722.0010.0010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.001742.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.01541.500-3.230[0.5 - 2]
operatingCashFlowSalesRatioTTM0.07741.000-0.5660[0.1 - 0.5]
Total Score0.313

Dimerix Ltd

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico